| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.0M | +19.0% |
| R&D Expense | $3.1M | -6.8% |
| SG&A Expense | $2.7M | -19.6% |
| Operating Income | -$2.8M | +32.6% |
| Income Tax | $0 | — |
| Net Income | -$2.7M | +32.3% |
| EPS (Basic) | -$1.58 | +38.5% |
| EPS (Diluted) | -$1.58 | +38.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Current Assets | $8.0M | +22.2% |
| Total Assets | $8.4M | +21.2% |
| Current Liabilities | $968K | +8.2% |
| Total Liabilities | $968K | +8.2% |
| Stockholders' Equity | $7.4M | +23.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.3M | +18.8% |
| Financing Cash Flow | $4.0M | — |